Not a usual suspect; rabeprazole therapy presenting as a severe neuropsychiatric illness: Case report

International Journal of Psychiatry in Medicine

Volumn 33, Issue 3, 2003, Pages 311-315

  Alfonzo, Christopher A ^a,d   Bobo, William V ^b   Almond, Myron D ^c  

^a Naval Air Station   (United States)

^b NAVAL HOSPITAL JACKSONVILLE   (United States)

^c Naval Aerospace Medicine Institute   (United States)

^d NONE   (United States)

Author keywords

Adverse effects; Neuropsychiatric; Neuropsychological; Proton pump inhibitors; Rabeprazole; Somatoform

Indexed keywords

PLACEBO; PROTON PUMP INHIBITOR; RABEPRAZOLE;

ADULT; ANXIETY; ARTICLE; BACKACHE; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE SEVERITY; DIZZINESS; DRUG SAFETY; DRUG TOLERABILITY; FACE; GASTROESOPHAGEAL REFLUX; HEADACHE; HEALTH CARE UTILIZATION; HUMAN; LABORATORY TEST; MALE; MENTAL DISEASE; MENTAL STRESS; MUSCLE STIFFNESS; MUSCLE TWITCH; MUSCLE WEAKNESS; MYALGIA; NEUROPSYCHIATRY; PARESTHESIA; RADIODIAGNOSIS; SCALP; SOMATOFORM DISORDER; SYMPTOM; TREATMENT OUTCOME; TREMOR;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; BENZIMIDAZOLES; BRAIN; DIAGNOSIS, DIFFERENTIAL; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MENTAL DISORDERS; OMEPRAZOLE; PROTON-TRANSLOCATING ATPASES; SEVERITY OF ILLNESS INDEX; SOMATOFORM DISORDERS;

EID: 1542679813     PISSN: 00912174     EISSN: None     Source Type: Journal    
DOI: 10.2190/KX4X-UFK5-60KL-WD2G     Document Type: Article

References (9)

1. Vanderhoff BT, Tahboub RM. Proton pump inhibitors: An update. American Family Physician 2002;66:273-280.
2. Mermer C. Understated dangers of omeprazole. Rapid response to Bong JL, Lucke TW, Douglas WS. Drug points: Lichenoid drug eruption with proton pump inhibitors. British Medical Journal 2000;320:283. Retrieved in February 2003, from: http://bmj.com/cgi/eletters/320/7230/283.
3. Spitzer RL, Williams JB, Kroenke K, Linzer M, deGruy FV III, Hahn SR, Bong JL, Lucke TW, Douglas WS. Utility of a new procedure for diagnosing mental disorders in primary care: The PRIME-MD 1000 study. Journal of the American Medical Association 1994;272:1749-1756.
4. Rabeprazole (Aciphex). Package insert. Titusville, NJ: Janssen Pharmaceutica, 2002. Retrieved in February 2003, from: www.aciphex.com/aciphexpi.pdf.
5. Reilly JP. Safety profile of the proton-pump inhibitors. American Journal of Health System Pharmacology 1999;56(23 suppl 4):S11-S17.
6. Prakash A, Faulds D. Rabeprazole. Drugs 1998;55:261-267.
7. Natsch S, Vinks MH, Voogt AK, Mees EB, Meyboom RH. Anaphylactic reactions to proton-pump inhibitors. Annals of Pharmacotherapy 2000;34:474-476.
8. Marcuard SP, Albernaz L, Khazanie PG. Omeprazole therapy causes malabsorption of cyanocobalamin (vitamin B-12). Annals of Internal Medicine 1994;120:211-215.
9. Oommen T. Making the same mistake twice. Rapid response to Bong JL, Lucke TW, Douglas WS. Drug points: Lichenoid drug eruption with proton pump inhibitors. British Medical Journal 2000;320:283. Retrieved in February 2003, from: http://bmj.com/cgi/eletters/320/7230/283.